{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:56:03Z","timestamp":1790826963285,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Updating live vaccines such as measles, mumps, rubella, and varicella (MMRV) is an important step in preparing patients for solid organ transplant (SOT) to prevent morbidity from these preventable diseases. However, data for this approach are scarce. Thus, we aimed to describe the seroprevalence of MMRV and the efficacy of the vaccines in our transplant center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Pre-SOT candidates &gt;18 y of age were retrospectively retrieved from SOT database in Memorial Hermann Hospital Texas Medical Center. MMRV serologies are routinely screened at the time of pretransplant evaluation. We divided patients into 2 groups: MMRV-positive group versus MMRV-negative group, patients with positive all MMRV serologies and with negative immunity to at least 1 dose of MMRV, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>A total of 1213 patients were identified. Three hundred ninety-four patients (32.4%) did not have immunity to at least 1 dose of MMRV. Multivariate analysis was conducted. Older age (odds ratio [OR]: 1.04) and liver transplant candidates (OR: 1.71) were associated with seropositivity. Previous history of SOT (OR: 0.54) and pancreas\/kidney transplant candidates (OR: 0.24) were associated with seronegativity. Among 394 MMRV seronegative patients, 60 patients received 1 dose of MMR vaccine and 14 patients received 1 dose of varicella-zoster virus vaccine without severe adverse events. A total of 35% (13\/37) of patients who had follow-up serologies did not have a serological response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>A significant number of pre-SOT candidates were not immune to at least 1 dose of MMRV. This highlights the importance of MMRV screening and vaccinations pre-SOT. Postvaccination serological confirmation should be performed to evaluate the necessity for a second dose.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004681","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:01:01Z","timestamp":1686628861000},"page":"2279-2284","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Seroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus and Seroresponse to the Vaccinations in Adult Solid Organ Transplant Candidates"],"prefix":"10.1097","volume":"107","author":[{"given":"Hana","family":"Javaid","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"De Golovine","sequence":"additional","affiliation":[{"name":"Division of Renal Disease, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Hasbun","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Jyothula","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Pulmonary, Sleep and Lung Transplant Medicine, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Machicao","sequence":"additional","affiliation":[{"name":"Division of Transplant Hepatology, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Bynon","sequence":"additional","affiliation":[{"name":"Division of Immunology and Organ Transplantation, Department of Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ostrosky","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nigo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.clinthera.2017.07.005","article-title":"A comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients.","volume":"39","author":"Chong","year":"2017","journal-title":"Clin Ther"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","article-title":"Epidemiology of varicella during the 2-dose varicella vaccination program\u2014United States, 2005-2014.","volume":"65","author":"Lopez","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1016\/j.ijid.2009.06.013","article-title":"Acute measles infection triggering an episode of liver transplant rejection.","volume":"14","author":"Sternfeld","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1600-6143.2009.02732.x","article-title":"Mumps: not an innocent bystander in solid organ transplantation.","volume":"9","author":"Baas","year":"2009","journal-title":"Am J Transplant"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00006454-199402000-00020","article-title":"Rubella infection after orthotopic liver transplantation.","volume":"13","author":"Mazariegos","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"e3733","DOI":"10.1093\/cid\/ciaa824","article-title":"Measles, mumps, rubella, and varicella zoster virus serology and infections in solid organ transplant recipients during the first year posttransplantation.","volume":"73","author":"Rezahosseini","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/ajt.16278","article-title":"Measles outbreak risk assessment for transplant candidates and recipients.","volume":"21","author":"Kreiger-Benson","year":"2021","journal-title":"Am J Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.transproceed.2019.01.092","article-title":"Varicella-zoster virus-induced hepatitis in a liver transplant recipient: a case report.","volume":"51","author":"Acar","year":"2019","journal-title":"Transplant Proc"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.12998\/wjcc.v9.i30.9168","article-title":"Fatal visceral disseminated varicella-zoster virus infection in a renal transplant recipient: a case report.","volume":"9","author":"Wang","year":"2021","journal-title":"World J Clin Cases"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American Society of Transplantation infectious diseases community of practice.","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"R18-20250604","first-page":"159","article-title":"Serologic screening and infectious diseases consultation in renal transplant candidates for measles, mumps, rubella and varicella.","volume":"59","author":"Seckin","year":"2021","journal-title":"Rom J Intern Med"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/522866","article-title":"Seroprevalence of measles antibody in the US population, 1999\u20132004.","volume":"196","author":"McQuillan","year":"2007","journal-title":"J Infect Dis"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"ofv006","DOI":"10.1093\/ofid\/ofv006","article-title":"Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009\u20132010.","volume":"2","author":"Lebo","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"e2118508","DOI":"10.1001\/jamanetworkopen.2021.18508","article-title":"Seroprevalence of measles and mumps antibodies among individuals with cancer.","volume":"4","author":"Marquis","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1111\/ajt.16602","article-title":"Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation.","volume":"21","author":"Hostetler","year":"2021","journal-title":"Am J Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.vaccine.2021.01.028","article-title":"Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden\u2014an interrupted time-series analysis.","volume":"40","author":"S\u00f8rup","year":"2022","journal-title":"Vaccine"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: implications for MMR vaccine-induced protection.","volume":"206","author":"Kontio","year":"2012","journal-title":"J Infect Dis"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/vaccines8010066","article-title":"Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy.","volume":"8","author":"Anichini","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-020-20226-9","article-title":"Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom.","volume":"12","author":"Murphy","year":"2021","journal-title":"Nat Commun"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1097\/TP.0000000000002722","article-title":"Immunity to vaccine-preventable viral infections in Australians being evaluated for liver transplantation.","volume":"103","author":"Gardiner","year":"2019","journal-title":"Transplantation"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3201\/eid2804.212357","article-title":"Vaccine-associated measles encephalitis in immunocompromised child, California, USA.","volume":"28","author":"Costales","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/TP.0000000000003621","article-title":"Evaluation of recombinant herpes zoster vaccine for primary immunization of varicella-seronegative transplant recipients.","volume":"105","author":"L\u2019Huillier","year":"2021","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:15:04Z","timestamp":1749060904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004681","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,13]]}}}